|
Diagnostic performance of 18F-DCFPyL in the OSPREY Trial: A prospective phase 2/3 multicenter study of 18F-DCFPyL PET/CT imaging in patients (Pts) with known or suspected metastatic prostate cancer (mPC). |
|
|
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bayer; Blue Earth Diagnostics; Endocyte; Tokai Pharmaceuticals; Tolmar |
Speakers' Bureau - ORIC Pharmaceuticals |
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Bayer; Endocyte |
|
|
Stock and Other Ownership Interests - Adient Medical |
Consulting or Advisory Role - Adient Medical |
Patents, Royalties, Other Intellectual Property - Patent disclosures, provisionals submitted for instrument to analyze biopsy specimens (unrelated to the small renal masses topic). Patent holder for device related to x-ray imaging data collection (unrelated to small renal masses topic)....July 2008. |
Other Relationship - Society of Interventional Radiology Foundation |
|
|
Consulting or Advisory Role - AstraZeneca; Merck |
Speakers' Bureau - AstraZeneca |
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Prometheus (Inst); Roche (Inst) |
|
|
No Relationships to Disclose |
|
|
Research Funding - Progenics (Inst) |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; EMD Serono; Jounce Therapeutics; Pfizer/EMD Serono; Sanofi |
Speakers' Bureau - AstraZeneca; Dendreon; Genentech/Roche; Genomic Health; Merck; Sanofi |
Research Funding - Janssen Oncology |
Travel, Accommodations, Expenses - Genentech/Roche |
|
|
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Genzyme; Janssen; Pfizer; Sanofi |
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Genzyme; Janssen; Pfizer; Progenics; Sanofi |
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Sanofi |
Research Funding - Astellas Pharma; AstraZeneca; Janssen; Merck (Inst); Progenics (Inst); Sanofi |
Patents, Royalties, Other Intellectual Property - Universite Laval |
|
|
Research Funding - Progenics (Inst) |
|
|
No Relationships to Disclose |
|
|
Employment - LeMaitre Vascular (I) |
Honoraria - Astellas Pharma; Bayer; Janssen |
Research Funding - Bayer; Janssen (Inst) |
Travel, Accommodations, Expenses - Genentech |
|
|
Research Funding - Progenics (Inst) |
|
|
Honoraria - Intuitive Surgical |
Consulting or Advisory Role - Nutcracker Therapeutics, Inc. |
|
|
Research Funding - Progenics (Inst) |
|
|
Leadership - CUE Biopharma |
Stock and Other Ownership Interests - CUE Biopharma |
Honoraria - Johnson & Johnson; Progenics |
Consulting or Advisory Role - CUE Biopharma |
Research Funding - Progenics |
Travel, Accommodations, Expenses - CUE Biopharma |
|
|
|
Stock and Other Ownership Interests - Progenics |
|
|
|
|
Stock and Other Ownership Interests - Progenics |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Blue Earth Diagnostics; BTG; Curium Pharma; GE Healthcare; GlaxoSmithKline; ImaginAb; Progenics |
Research Funding - Blue Earth Diagnostics; ImaginAb; Progenics |
Travel, Accommodations, Expenses - Siemens (I) |